Om inget annat anges tillhör BD, BD-logotypen och alla övriga varumärken Becton, Dickinson and Company. © BD Om BD | Meddelande om sekretess | Villkor | Cookiealternativ

FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular Multi-Drug Resistant Tuberculosis (MDR-TB) Assay was included in the moderate complexity automated NAAT class of molecular diagnostic technologies that were recognized for high diagnostic accuracy for tuberculosis testing by the World Health Organization (WHO) in advance of an update to its guidelines

The segment's results were driven by strong sales related to COVID-19 diagnostic testing solutions in the Diagnostic Systems unit on the BD Veritor TM and BD Max TM FRANKLIN LAKES, N.J., Oct. 31, 2016 /PRNewswire/ -- BD , a leading global medical technology company, today announced U.S. Food and Drug Administration market authorization for a | February 9, 2021 Find the latest Becton, Dickinson and Company (BDX) stock quote, history, news and other vital information to help you with your stock trading and investing. Becton Dickinson said in a statement that it had "received reports of elevated rates of potential false positive results from certain customers experiencing the issue when using the BD SARS-CoV-2 Becton, Dickinson and Company BDX, also known as BD, recently announced the FDA 510(k) clearance of its BD MAX enteric viral panel, a molecular diagnostic test for the direct qualitative detection 2016-09-15 · Leading global medical technology company, Becton, Dickinson and Company BDX recently announced that it got the clearance for its proprietary BD MAX. 2021-04-14 · BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the second quarter of fiscal year 2021 on Thursday, May 6, 2021. 2021-01-07 · Becton Dickinson & Co. 7 Loveton Cir Sparks MD 21152-9212: For Additional Information Contact: Gail Griffiths 410-316-4054 Manufacturer Reason for Recall: Some N1 and N2 master mix pouches packaged within the lots of BioGX SARS-CoV-2 Reagents for BD MAX System may be mislabeled. Description: Year: Literature # BD EpiCenter™ and Bruker MALDI Biotyper Integration Pilot Study: 2011 LR223494 Evaluation of the Becton Dickinson Phoenix and bioMérieux VITEK Legacy Automated Microbiology Identification and Antimicrobial Susceptibility Systems. 2020-08-06 · Becton Dickinson said production of its recently approved rapid test for the coronavirus strain Covid-19 will ramp up to 12 million tests per month by the end of February 2021.

Becton dickinson bd max

The BD MAX System is capable of: Independent nucleic acid extraction and purification; PCR amplification using thermal cycling across 24 lanes; Real time Eur J Clin Microbiol Infect Dis. 2015;34(5):1005-1009. 6. BD MAX™Enteric Bacterial Panel [package insert]. Becton, Dickinson and Company. Narrowed By: Becton Dickinson (BD) MAX™ Product · Clear All · BD MAX™ CT/ GC/TV 20-Day QC Panel · Log in to see price.

FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala., April 3, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for * The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect FRANKLIN LAKES, N.J., Jan. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported, preliminary unaudited financial information for the first fiscal quarter ended Dec. 31, 2020. 2021-02-12 · FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new molecular diagnostic test for both SARS-CoV-2 and Influenza A+B that can return results in two to three hours.

BD (Becton, Dickinson and Company), Franklin Lakes, NJ. 24,688 likes · 881 talking about this · 2,966 were here. BD is a global medical technology company that is advancing the world of health by

US-224004 Printed in the USA, March 2018. BD, Sparks, MD 21152-0999 USA 800.638.8663 Enhance the overall patient therapy and Om inget annat anges tillhör BD, BD-logotypen och alla övriga varumärken Becton, Dickinson and Company. © BD Om BD | Meddelande om sekretess | Villkor | Cookiealternativ BD molecular diagnostic solutions include a diverse product offering designed to maximize efficiency and flexibility through broad menu and throughput capabilities, and to redefine staff productivity.

Eur J Clin Microbiol Infect Dis. 2015;34(5):1005-1009. 6. BD MAX™Enteric Bacterial Panel [package insert]. Becton, Dickinson and Company.

Sparks, MD 21152 . Device: BD SARS-CoV-2/Flu for BD MAX System .

2021-02-10 · BD Integrated Diagnostics Solution Division . Becton, Dickinson and Company .
Boendeassistenter lön

ZARAGOZA, Spain and FRANKLIN LAKES, N.J., March 10, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX ™ System has been CE marked to the IVD Directive (98/79/CE).

2019-10-30 · BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular ZARAGOZA, Spain and FRANKLIN LAKES, N.J., Oct. 21, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit adapted for the BD MAX™ System has been CE marked* to the IVD Directive (98/79/EC). FRANKLIN LAKES, N.J., Oct. 16, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX™ MDR-TB panel in Europe. 2020-04-02 · Page 3 – Sherma Winston, M.S., RAC, Becton, Dickinson & Company (BD) SARS-CoV-2 Reagents for BD MAX System (lyophilized reagents for multiplexed detection of N2 and RNase P), and BioGX Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products.
Föra över kontakter iphone

rund botten (Becton Dickinson, kat.nr. 352051). BD#352051. FalconPP Fyll inte provröret med mer än 1,9 ml (dvs. max 12 prover per provrör). Om mer än 12.

Bioz Stars score: 93/100, based on 2 PubMed citations. 2021-01-07 Sparks, Maryland -BD Diagnostics, a segment of leading global medical technology company BD , announced today the availability of the FDA-cleared BD MAX™ Enteric Bacterial | April 12, 2021 SPARKS, Md., May 7, 2014 /PRNewswire/ -- BD Diagnostics, a segment of leading global medical technology company BD , announced today the availability of the FDA-cleared BD MAX Enteric | … FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new molecular diagnostic test for both SARS-CoV-2 and Influenza A+B that can return results in two to three hours.